Diltiazem Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type ; Application, and Geography

Diltiazem Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type ; Application, and Geography

  • August 2021 •
  • 177 pages •
  • Report ID: 6154033 •
  • Format: PDF
The diltiazem market is projected to reach US$ 832.51 million by 2028 from US$ 369.95 million in 2021; it is expected to grow at a CAGR of 12.3% from 2021 to 2028.

The rising rate of coronavirus results in increased stress on the region’s healthcare system, increasing the need for diagnostic tests in its healthcare system, encouraging the expansion of the sector in this region.As of 4 August 2021, the virus has affected over 51,859,200 people across the region and killed at least 1,137,425, as per Worldometer.

Also, Italy, Spain, Germany, France, and the UK are the most affected European nations.As per the data given by Worldometer, till 4 August 2021, France, the UK, Spain, Italy, and Germany recorded 6,178,632; 5,923,820; 4,523,310; 4,363,374; and 3,782,326; respectively.

COVID-19 cases and the death counts are also huge in these nations.

Hypertension has been recorded in various cases and retrospective groups as a possible risk factor for the frequency and severity of new SARS-CoV-2-associated disease (COVID-19).Since the SARS-CoV-2’s high infectivity rates, a possible interaction between COVID-19 and hypertension is worrisome.

Diltiazem may be helpful to treat hypertension associated with COVID-19.Further, diltiazem was proclaimed to alleviate acute lung injury by suppressing neutrophilic oxidative stress, which may relieve acute lung injury in COVID-19 patients.

Overall, diltiazem plays dual effects on hypertension-linked COVID-19 treatment by lowering high blood pressure and restraining NF-kb signaling pathway-related inflammation.

The region witnessed some shortfall at the beginning of the COVID-19 crisis due to disruption in supply chain and demand due to lockdown announced by most European countries.Market players and end user lost their business due to the temporarily shutting down of industries in various regions.

However, the diltiazem market witnessed growth during the pandemic as it is anticipated to inhibit viral growth and related hypertension.The global diltiazem market is segmented based on product type and application.

Based on product type, In 2021, the tablets segment held the largest share of the market, by product.However, The capsules segment of Diltiazem market is also expected to witness fastest CAGR during 2021 to 2028.

Moreover, based on application into angina, hypertension, and others. In 2021, the hypertension segment held the largest share of the market, by application. Whereas the Angina segment is expected to grow at the fastest CAGR of 12.9% during the coming years.

The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and National Health and Wellness are among the primary and secondary sources referred to while preparing the report on the Diltiazem market.

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.